Literature DB >> 25152225

High frequency of adult attention deficit hyperactivity disorder among fibromyalgia patients in the Netherlands: should a systematic collaboration between rheumatologists and psychiatrists be sought?

Marees Th Derksen1, M J W Vreeling2, Ilja Tchetverikov3.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25152225

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  6 in total

1.  Adult ADHD and Comorbid Somatic Disease: A Systematic Literature Review.

Authors:  Johanne Telnes Instanes; Kari Klungsøyr; Anne Halmøy; Ole Bernt Fasmer; Jan Haavik
Journal:  J Atten Disord       Date:  2016-09-01       Impact factor: 3.256

2.  Chronic Pain And Health-Related Quality Of Life In Women With Autism And/Or ADHD: A Prospective Longitudinal Study.

Authors:  Karin Asztély; Svenny Kopp; Christopher Gillberg; Margda Waern; Stefan Bergman
Journal:  J Pain Res       Date:  2019-10-18       Impact factor: 3.133

3.  Pain and Attention-Deficit/Hyperactivity Disorder: The Case of Margaret Mitchell.

Authors:  Satoshi Kasahara; Ko Matsudaira; Naoko Sato; Shin-Ichi Niwa
Journal:  Psychosom Med       Date:  2021-06-01       Impact factor: 4.312

4.  Case report: Treatment of persistent atypical odontalgia with attention deficit hyperactivity disorder and autism spectrum disorder with risperidone and atomoxetine.

Authors:  Satoshi Kasahara; Chihiro Takao; Ko Matsudaira; Naoko Sato; Trang Thi Huyen Tu; Shin-Ichi Niwa; Kanji Uchida; Akira Toyofuku
Journal:  Front Pain Res (Lausanne)       Date:  2022-07-22

5.  Attention-deficit hyperactivity disorder and impulsivity in female patients with fibromyalgia.

Authors:  Ertan Yılmaz; Lut Tamam
Journal:  Neuropsychiatr Dis Treat       Date:  2018-07-24       Impact factor: 2.570

6.  Attention-deficit hyperactivity disorder symptoms and quality of life in female patients with fibromyalgia

Authors:  Gözde Türkoğlu
Journal:  Turk J Med Sci       Date:  2021-08-30       Impact factor: 0.973

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.